-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L4yY7znguUrjKzWLPNmVTuXFQqgtjCcw/qYsYTSatvZE4ZNX6o5I6OzBzIriAvjc aLN5P7HqQN0OlNzwm0/afw== 0001138723-10-000008.txt : 20100106 0001138723-10-000008.hdr.sgml : 20100106 20100106153516 ACCESSION NUMBER: 0001138723-10-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100104 FILED AS OF DATE: 20100106 DATE AS OF CHANGE: 20100106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WINGER DENNIS L CENTRAL INDEX KEY: 0001222645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33301 FILM NUMBER: 10511473 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCURAY INC CENTRAL INDEX KEY: 0001138723 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 770268932 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 BUSINESS PHONE: 4087164600 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-01-04 0 0001138723 ACCURAY INC ARAY 0001222645 WINGER DENNIS L 1310 CHESAPEAKE TERRACE SUNNYVALE CA 94089 1 0 0 0 Non-Qualified Stock Option (right to buy) 5.68 2010-01-04 4 A 0 36795 0 A 2020-01-04 Common Stock 36795 36795 D This grant is based on annual option grant guidelines for each non-employee director receiving an annual option grant equal to the number of shares obtained by dividing $120,000 by the Black-Scholes valuation of one share of our common stock. As of January 4, 2010, the Black-Scholes valuation of one share of our common stock was $3.2613. These options are exercisable as they vest. Fifty percent (50%) of the shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 12-months. The remaining fifty percent (50%) of the shares become vested and fully exercisable in equal monthly installments, ratably over the next period of 24-months. By: Lori Serrano For: Dennis Winger 2010-01-05 -----END PRIVACY-ENHANCED MESSAGE-----